Literature DB >> 27658679

What is rheumatoid arthritis? Considering consequences of changed classification criteria.

Annette H M van der Helm-van Mil1,2, Angela Zink3,4.   

Abstract

Entities:  

Keywords:  Autoantibodies; Disease Activity; Rheumatoid Arthritis

Mesh：

Substances：

Year:  2016        PMID： 27658679     DOI： 10.1136/annrheumdis-2016-209629

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  14 in total

1.  [How frequent are poor prognostic markers in rheumatoid arthritis? : An estimate based on three epidemiologic cohorts].

Authors:  K Albrecht; A Richter; Y Meissner; D Huscher; L Baganz; K Thiele; M Schneider; A Strangfeld; A Zink
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

2.  Evaluation of the predictive accuracy of MRI-detected erosions in hand and foot joints in patients with undifferentiated arthritis.

Authors:  Debbie M Boeters; Aleid C Boer; Annette H M van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2018-07-31       Impact factor: 19.103

3.  The use of MRI-detected synovitis to determine the number of involved joints for the 2010 ACR/EULAR classification criteria for Rheumatoid Arthritis - is it of additional benefit?

Authors:  Aleid C Boer; Debbie M Boeters; Annette H M van der Helm-van Mil
Journal:  Ann Rheum Dis       Date:  2018-04-20       Impact factor: 19.103

4.  Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients.

Authors:  Cristina Regueiro; Laura Nuño; Ana M Ortiz; Diana Peiteado; Alejandro Villalba; Dora Pascual-Salcedo; Ana Martínez-Feito; Isidoro González-Alvaro; Alejandro Balsa; Antonio González
Journal:  Sci Rep       Date:  2017-09-20       Impact factor: 4.379

5.  Sequence of joint tissue inflammation during rheumatoid arthritis development.

Authors:  R M Ten Brinck; H W van Steenbergen; A H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2018-11-21       Impact factor: 5.156

6.  Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial.

Authors:  Lena Bugge Nordberg; Siri Lillegraven; Anna-Birgitte Aga; Joseph Sexton; Inge Christoffer Olsen; Elisabeth Lie; Hilde Berner Hammer; Till Uhlig; Desirée van der Heijde; Tore K Kvien; Espen A Haavardsholm
Journal:  RMD Open       Date:  2018-11-16

7.  Is Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis Still a More Severe Disease Than Anti-Citrullinated Protein Antibody-Negative Rheumatoid Arthritis? A Longitudinal Cohort Study in Rheumatoid Arthritis Patients Diagnosed From 2000 Onward.

Authors:  Aleid C Boer; Annelies Boonen; Annette H M van der Helm van Mil
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-05-28       Impact factor: 4.794

Review 8.  Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectives.

Authors:  Leonie E Burgers; Karim Raza; Annette H van der Helm-van Mil
Journal:  RMD Open       Date:  2019-04-03

9.  What is the additional value of MRI of the foot to the hand in undifferentiated arthritis to predict rheumatoid arthritis development?

Authors:  Y J Dakkak; D M Boeters; A C Boer; M Reijnierse; A H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2019-02-14       Impact factor: 5.156

10.  A search to the target tissue in which RA-specific inflammation starts: a detailed MRI study to improve identification of RA-specific features in the phase of clinically suspect arthralgia.

Authors:  Xanthe M E Matthijssen; Fenne Wouters; Debbie M Boeters; Aleid C Boer; Yousra J Dakkak; Ellis Niemantsverdriet; Annette H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2019-11-27       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.